Suppr超能文献

甲状腺疾病中苯妥英钠代谢未受影响。

Unaltered metabolism of phenytoin in thyroid disorders.

作者信息

Mølholm Hansen J, Skovsted L, Kampmann J P, Lumholtz B I, Siersbaek-Nielsen K

出版信息

Acta Pharmacol Toxicol (Copenh). 1978 May;42(5):343-6. doi: 10.1111/j.1600-0773.1978.tb02214.x.

Abstract

The metabolism of phenytoin was studied in 9 hyperthyroid and 7 hypothyroid patients before and after treatment with either antithyroid drugs or 1-thyroxine. No difference in the half-life, volume of distribution and metabolic clearance rate was found between untreated hyper- and hypothyroid subjects. Furthermore, normalisation of thyroid function test did not change the kinetic parameters of phenytoin. The results indicate that the well-known correlation between thyroid function and antipyrine kinetics cannot be extrapolated uncritically to other drugs. It is concluded that no general rules are valid in the kinetics among different drugs in thyroid pathological conditions. Each drug must be evaluated by itself in different pathological conditions.

摘要

在9名甲状腺功能亢进患者和7名甲状腺功能减退患者中,研究了在使用抗甲状腺药物或左甲状腺素治疗前后苯妥英的代谢情况。未经治疗的甲状腺功能亢进和减退受试者之间,在半衰期、分布容积和代谢清除率方面未发现差异。此外,甲状腺功能测试的正常化并未改变苯妥英的动力学参数。结果表明,甲状腺功能与安替比林动力学之间的众所周知的相关性不能不加批判地外推到其他药物。得出的结论是,在甲状腺病理状态下,不同药物的动力学中不存在普遍适用的规则。每种药物都必须在不同的病理状态下单独进行评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验